98 related articles for article (PubMed ID: 37459055)
1. Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees.
Leath CA; Nysenbaum J; Ting J; Zhang YJ; Fiori A; Pauly N
Am J Clin Oncol; 2023 Sep; 46(9):392-398. PubMed ID: 37459055
[TBL] [Abstract][Full Text] [Related]
2. Patterns of care and health care resource use among Medicaid-enrolled women with recurrent or metastatic cervical cancer.
Leath CA; Nysenbaum J; Ting J; Zhang YJ; Fiori A; Pauly N
J Manag Care Spec Pharm; 2023 May; 29(5):490-498. PubMed ID: 37121257
[No Abstract] [Full Text] [Related]
3. Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer.
Castellano T; Moore K; Ting J; Washington C; Yildiz Y; Surinach A; Sonawane K; Chhatwal J; Ayer T
Gynecol Oncol; 2023 Feb; 169():113-117. PubMed ID: 36549175
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
Alholm Z; Monk BJ; Ting J; Pulgar S; Boyd M; Sudharshan L; Bains S; Nicacio L; Coleman RL
Gynecol Oncol; 2021 May; 161(2):422-428. PubMed ID: 33741208
[TBL] [Abstract][Full Text] [Related]
5. Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
Tsui J; DeLia D; Stroup AM; Nova J; Kulkarni A; Ferrante JM; Cantor JC
Cancer; 2019 Apr; 125(8):1330-1340. PubMed ID: 30561793
[TBL] [Abstract][Full Text] [Related]
6. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.
Sonawane K; Castellano T; Washington C; Ting J; Surinach A; Kirshner C; Chhatwal J; Ayer T; Moore K
Gynecol Oncol Rep; 2022 Dec; 44():101121. PubMed ID: 36589508
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.
Sonawane K; Castellano T; Washington C; Ting J; Surinach A; Kirshner C; Chhatwal J; Ayer T; Moore K
Gynecol Oncol Rep; 2022 Dec; 44(Suppl 1):101101. PubMed ID: 36506039
[TBL] [Abstract][Full Text] [Related]
9. Racial and urban/rural differences in cervical carcinoma in Georgia Medicaid recipients.
Sung JF; Blumenthal DS; Alema-Mensah E; McGrady GA
Cancer; 1997 Jul; 80(2):231-6. PubMed ID: 9217035
[TBL] [Abstract][Full Text] [Related]
10. Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia.
Walkup J; Akincigil A; Hoover DR; Siegel MJ; Amin S; Crystal S
Public Health Rep; 2011; 126 Suppl 3(Suppl 3):89-101. PubMed ID: 21836742
[TBL] [Abstract][Full Text] [Related]
11. National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United States.
Patel C; Pilon D; Gupta D; Morrison L; Lafeuille MH; Lefebvre P; Benson C
J Med Econ; 2022; 25(1):792-807. PubMed ID: 35635250
[TBL] [Abstract][Full Text] [Related]
12. Multiple chronic conditions among Medicare beneficiaries: state-level variations in prevalence, utilization, and cost, 2011.
Lochner KA; Goodman RA; Posner S; Parekh A
Medicare Medicaid Res Rev; 2013; 3(3):. PubMed ID: 24753976
[TBL] [Abstract][Full Text] [Related]
13. Patterns of cervical cancer screening, diagnosis, and follow-up treatment in a state Medicaid fee-for-service population.
Nadpara PA; Madhavan SS; Khanna R; Smith M; Miller LA
Popul Health Manag; 2012 Dec; 15(6):362-71. PubMed ID: 22788858
[TBL] [Abstract][Full Text] [Related]
14. Breast, Cervical, and Colorectal Cancer Screening: Patterns Among Women With Medicaid and Commercial Insurance.
Bonafede MM; Miller JD; Pohlman SK; Troeger KA; Sprague BL; Herschorn SD; Winer IH
Am J Prev Med; 2019 Sep; 57(3):394-402. PubMed ID: 31377088
[TBL] [Abstract][Full Text] [Related]
15. Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer.
Musa FB; Brouwer E; Ting J; Schwartz NRM; Surinach A; Bloudek L; Ramsey SD
Gynecol Oncol; 2022 Mar; 164(3):645-650. PubMed ID: 35031189
[TBL] [Abstract][Full Text] [Related]
16. Patterns and correlates of cervical cancer screening initiation in a large integrated health care system.
Becerra-Culqui TA; Lonky NM; Chen Q; Chao CR
Am J Obstet Gynecol; 2018 Apr; 218(4):429.e1-429.e9. PubMed ID: 29277629
[TBL] [Abstract][Full Text] [Related]
17. Do medical homes increase medication adherence for persons with multiple chronic conditions?
Beadles CA; Farley JF; Ellis AR; Lichstein JC; Morrissey JP; DuBard CA; Domino ME
Med Care; 2015 Feb; 53(2):168-76. PubMed ID: 25517069
[TBL] [Abstract][Full Text] [Related]
18. Cancer burden in women with HIV on Medicaid: A nationwide analysis.
Zhou G; Koroukian SM; Navale SM; Schiltz NK; Kim U; Rose J; Cooper GS; Moore SE; Mintz LJ; Avery AK; Mukherjee S; Markt SC
Womens Health (Lond); 2023; 19():17455057231170061. PubMed ID: 37184054
[TBL] [Abstract][Full Text] [Related]
19. Improvements in Air Quality and Health Outcomes Among California Medicaid Enrollees Due to Goods Movement Actions.
Meng YY; Su JG; Chen X; Molitor J; Yue D; Jerrett M
Res Rep Health Eff Inst; 2021 May; 2021(205):1-61. PubMed ID: 35869754
[TBL] [Abstract][Full Text] [Related]
20. Oral Cancer Prevalence, Mortality, and Costs in Medicaid and Commercial Insurance Claims Data.
Tranby EP; Heaton LJ; Tomar SL; Kelly AL; Fager GL; Backley M; Frantsve-Hawley J
Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1849-1857. PubMed ID: 35732291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]